Managing COVID-19 epidemics in low- to middle-income and crisis-affected settings: Epidemiological and economic evaluation

Grant number: 221303/Z/20/Z

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $234,534.48
  • Funder

    Wellcome Trust
  • Principal Investigator

    Prof Francesco Checchi
  • Research Location

    United Kingdom
  • Lead Research Institution

    London School of Hygiene & Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Policy research and interventions

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The COVID-19 pandemic is rapidly escalating and poses a potentially catastrophic threat to low and middle-income countries (LMICs) as well as crisis-affected populations. To support evidence-based, real-time decision- making by countries, donors, humanitarian actors and other stakeholders, the London School of Hygiene and Tropical Medicine (LSHTM) hereby proposes a six- month multi-disciplinary project. The project is built around three Workstreams: (1) Evaluation of the health, fiscal and macro-economic impact of response options; (2) Global analysis; and (3) Technical support to decision- makers and local researchers. Specific activities (and associated deliverables) include the following: - Improve global data collation and capacity for economic analysis around COVID-19 - Evaluate the health and economic implications of COVID-19 response options using micro-economic models - Quantify the macro-economic consequences of COVID-19 response options - Predict the transmission and mortality of alternative shielding options for high-risk populations - Provide a regular series of global COVID-19 health impact, resource needs and cost estimates - Advise LMIC governments, donors and humanitarian actors on COVID-19 strategy - Support technical guidance and coordination for humanitarian actors - Support LMIC economists to provide local evidence on COVID-19 responses We propose to undertake the above largely through desk-based work from London over a period of 6 months (Apr-Sep 2020).

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020.

Estimating RSV seasonality from pandemic disruptions: a modelling study

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.

Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study.

The local burden of disease during the first wave of the COVID-19 epidemic in England: estimation using different data sources from changing surveillance practices.

The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.